Cargando…
Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of (131)iodine treatment
Hepatic dysfunction is often observed in patients with Graves’ hyperthyroidism. The aims of this study were to investigate the risk factors for hepatic dysfunction and to analyze the efficacy of (131)I (radioactive iodine-131) treatment. In total, 2385 patients with Graves’ hyperthyroidism (478 male...
Autores principales: | Wang, Renfei, Tan, Jian, Zhang, Guizhi, Zheng, Wei, Li, Chengxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293474/ https://www.ncbi.nlm.nih.gov/pubmed/28151911 http://dx.doi.org/10.1097/MD.0000000000006035 |
Ejemplares similares
-
Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study
por: Wang, Renfei, et al.
Publicado: (2017) -
Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017) -
Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
por: Yu, Feng, et al.
Publicado: (2021) -
Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018) -
Prediction of thyroidal (131)I effective half-life in patients with Graves' disease
por: Zhang, Ruiguo, et al.
Publicado: (2017)